Bacillus Anthracis

News - Bacillus Anthracis

Soligenix Demonstrates Robust Stability Results with its SGX204 Anthrax Vaccine

2012-01-18 06:00:00

PRINCETON, N.J., Jan. 18, 2012 /PRNewswire/ -- Soligenix, Inc.

Anthrax Capsule Vaccine Protects Monkeys From Lethal Infection

2012-01-13 11:58:12

Vaccination with the anthrax capsule—a naturally occurring component of the bacterium that causes the disease—protected monkeys from lethal anthrax infection.

Elusys Initiates Third Clinical Safety Study of Anthim, a New Anthrax Treatment; Company Successfully Completes Manufacturing at Commercial Scale

2011-10-24 13:41:00

PINE BROOK, N.J., Oct. 24, 2011 /PRNewswire/ -- Elusys Therapeutics, Inc.

Elusys Awarded $68 Million Contract to Develop Anthim for Intramuscular Pre- and Post-Exposure Prophylaxis of Anthrax Infection

2011-09-08 09:00:00

PINE BROOK, N.J., Sept. 8, 2011 /PRNewswire/ -- Elusys Therapeutics, Inc.

Nano Detector For Deadly Anthrax

2011-07-07 00:39:40

An automatic and portable detector that takes just fifteen minutes to analyze a sample suspected of contamination with anthrax is being developed by US researchers.

More News (73 articles) »